MDCX MEDICUS PHARMA LTD revenue, earnings and financials
For the quarter ended June 30, 2026, MEDICUS PHARMA LTD reported revenue of n/a, net income of −$11.6M and diluted EPS of −$0.21; for the fiscal year ended December 2025 revenue was n/a.
MDCX annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$34.4M, net income −$47.3M (margin n/a), EPS −$2.74
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$11.2M, net income −$11.2M (margin n/a), EPS −$1.16
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$4.73M, net income −$5.31M (margin n/a), EPS −$1.53
MDCX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$11.6M, EPS −$0.21
- Quarter ended Mar 31, 2026: revenue n/a, net income −$9.04M, EPS −$0.31
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$15.1M, EPS −$0.77
- Quarter ended Sep 30, 2025: revenue n/a, net income −$20.9M, EPS −$1.12
- Quarter ended Jun 30, 2025: revenue n/a, net income −$6.18M, EPS −$0.43
- Quarter ended Mar 31, 2025: revenue n/a, net income −$5.10M, EPS −$0.42
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$3.54M, EPS −$0.27
- Quarter ended Sep 30, 2024: revenue n/a, net income −$2.28M, EPS −$0.24
- Quarter ended Jun 30, 2024: revenue n/a, net income −$3.63M, EPS −$0.44
- Quarter ended Mar 31, 2024: revenue n/a, net income −$1.71M, EPS −$0.21
MDCX cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$22.8M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$10.2M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$4.16M, share buybacks n/a
MDCX balance sheet
- Jun 30, 2026: cash $15.2M, total assets $27.1M, total liabilities $28.8M, shareholders' equity −$1.76M
- Mar 31, 2026: cash $6.37M, total assets $7.43M, total liabilities $6.00M, shareholders' equity $1.33M
- Dec 31, 2025: cash $8.71M, total assets $10.1M, total liabilities $10.0M, shareholders' equity −$67.6K
- Sep 30, 2025: cash $8.66M, total assets $9.98M, total liabilities $10.8M, shareholders' equity −$910K
- Jun 30, 2025: cash $9.67M, total assets $11.9M, total liabilities $8.69M, shareholders' equity n/a
- Mar 31, 2025: cash $3.98M, total assets $5.66M, total liabilities $3.51M, shareholders' equity n/a
- Dec 31, 2024: cash $4.16M, total assets $5.65M, total liabilities $2.51M, shareholders' equity $3.13M
- Dec 31, 2023: cash $1.72M, total assets $1.89M, total liabilities $782K, shareholders' equity n/a
Is MDCX profitable?
No. MEDICUS PHARMA LTD lost $56.7M over the last four quarters.
What is MDCX's EPS?
Diluted earnings per share over the last four quarters were −$2.41; −$0.21 in the latest quarter.